NCI 6896: A phase I trial of suberoylanilide hydroxamic acid (SAHA) and 13-cis retinoic acid in the treatment of patients with advanced renal cell carcinoma (RCC) Meeting Abstract


Authors: Nanus, D. M.; Tagawa, S. T.; Dutcher, J. P.; Akhtar, N. H.; Saran, A.; Mazumdar, M.; Milowsky, M. I.; Gudas, L. J.
Abstract Title: NCI 6896: A phase I trial of suberoylanilide hydroxamic acid (SAHA) and 13-cis retinoic acid in the treatment of patients with advanced renal cell carcinoma (RCC)
Meeting Title: 2011 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 7 Suppl.
Meeting Dates: 2011 Feb 17-19
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-03-01
Language: English
ACCESSION: WOS:000208880700347
DOI: 10.1200/jco.2011.29.7_suppl.349
PROVIDER: wos
Notes: Meeting Abstract: 349 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors